期刊文献+

熟地平颤汤结合西医常规疗法治疗帕金森病的临床多中心随机对照研究 被引量:18

Clinical multicenter randomized controlled study on treatment of Parkinson's disease with "Shudi Pingchan Decoction" and western medicine
下载PDF
导出
摘要 目的观察具有滋补肝肾、通络解毒功效中药熟地平颤汤结合西医常规疗法治疗帕金森病的临床疗效。方法采用多中心、随机对照的方法 ,将120例病例随机分为治疗组和对照组各60例。对照组继续原有西药治疗,治疗组同时加用熟地平颤汤和蝎蜈胶囊,两组疗程均为3个月;观察两组临床疗效及治疗后帕金森病统一评分量表(UPDRS)第二分量表(运动功能判断)和第三分量表(病程中疾病发展程度的判断)评分、改良的Hoehn&Yahr分级、左旋多巴用量、"开关"现象变化情况。结果治疗组和对照组总有效率分别为43.33%、16.67%;组间疗效比较,差异有统计学意义(P<0.01)。治疗组可明显改善患者的运动症状,减少UP-DRS II(P<0.05)和UPDRS III(P<0.01)评分;对有开关现象者可延长开期时间,减少关期时间(P<0.05),而且未见明显毒副作用。结论熟地平颤汤结合西医常规疗法治疗帕金森病具有增效减毒作用。 Objective To observe the clinical efficacy of "Shudi Pingchan Decoction" and western medicine in the treatment of Parkinson's disease(PD).Methods The multicentre,randomized controlled trial was used in this observation.Total 120 subjects were divided into control group and control group,60 cases in each group.Control group was continued to use levodopa while the treatment group was treated with levodopa and "Shudi Pingchan Decoction",with a course of 3 months.The UPDRS scale and switching time were measured.Results The total effective rate was 43.33% in the treatment group and 16.67% in the control group,with a striking difference between them(P0.01).In the treatment group,the motor symptoms were obviously relieved,the scores of UPDRS Ⅱand UPDRS Ⅲ were reduced(P0.05,P0.01);the time of turn-off was extended while the time of turn-on was reducedz(P0.05).Conclusion "Shudi Pingchan Decoction" can help clinical effects and reduce adverse reactions.
出处 《上海中医药杂志》 2010年第6期3-6,共4页 Shanghai Journal of Traditional Chinese Medicine
基金 上海市科委重点项目(03-4119844) 上海市教委发展基金项目(03CK19) 国家自然科学基金项目(30472207)
关键词 帕金森病 中西医结合疗法 熟地平颤汤 Parkinson's disease integrative Chinese and western medicine "Shudi Pingchan Decoction"
  • 相关文献

参考文献9

二级参考文献17

  • 1袁灿兴,胡建华.滋补肝肾、通络解毒法治疗帕金森病30例[J].上海中医药杂志,2004,38(8):8-9. 被引量:40
  • 2何建成,袁灿兴,卫洪昌.美多巴和中药合用对帕金森病大鼠酪氨酸羟化酶(TH)及TH mRNA的影响[J].中国老年学杂志,2006,26(1):54-56. 被引量:9
  • 3巴茂文,刘振国,孔敏,杨红旗,陈生弟,陆国强.左旋多巴诱发帕金森病大鼠异动症模型的建立和评价[J].上海交通大学学报(医学版),2006,26(7):810-812. 被引量:15
  • 4全国锥体外系疾病讨论会.帕金森病及帕金森综合征的诊断标准和鉴别诊断[J].中华神经精神病杂志,1985,28(4):256-256.
  • 5Webster DD.Critical analysis of the disability in Parkinsons disease[J].Modern Treatment,1968,18(5):257.
  • 6CarmanLS, GageGH, ShultsCW. Partial lesion of the substantia nigra., relation between extent of lesion and rotational behavior. Brain Res. 1991; 553(2): 275 -283.
  • 7Sokoloff P, Schwartz JG. Novel dopamine receptors half a decade later. Trends Pharmacol Sci. 1995; 16 (8): 270-275.
  • 8Nakao N, Shintani-Mizushima A, Kakishita K. The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease. Exp Neurol. 2004, 188(1) : 65-73.
  • 9Brooks DJ, Ibanez V, Sawle GV. Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11c-raclopride and positron emission tomography. Ann Neurol. 1992; 31(2) : 184-192.
  • 10张旺明.帕金森病与细胞凋亡[J].国外医学(神经病学.神经外科学分册),1997,24(5):249-252. 被引量:7

共引文献552

同被引文献228

引证文献18

二级引证文献98

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部